Gronghui May 9 丨 Osaikang (002755)(002755worldcup2018qualifiersasia.SZ) announcedworldcup2018qualifiersasiaThe wholly-owned subsidiary Jiangsu Osaikang Pharmaceutical Co., Ltd. recently received the "Drug Registration Certificate" of isaconazole sulfate for injection approved and issued by the State Food and Drug Administration. Isaconazole is a broad-spectrum new triazole antifungal drug. It inhibits the synthesis of ergosterol, a key component of fungal cell membranes, by inhibiting the cytochrome P-450-dependent enzyme lanosterol 14-α-demethylase. The main indication is for adult patients with invasive aspergillosis and invasive mucormycosis.
